LAMEA Ophthalmic Laser Market: Industry Growth, Market Size, Share and Forecast 2019-2025

Latin America and Middle East African (LAMEA) Ophthalmic Laser Market is forecast to grow at a CAGR of 4.9% during the forecast period. The market for ophthalmic lasers in the LAMEA has growth opportunities due to the contribution of the countries such as Brazil, Israel, South Africa, and other countries from the rest of the world. The healthcare system in South Africa, Brazil, and Israel has improved over the years with infrastructural development and treatment of eye-related diseases. The factors contributing to the growth of the ophthalmic laser market in LAMEA include a rising prevalence of chronic eye diseases such as cataracts and glaucoma. Along with it, an increase in the number of eye patients, and awareness of advanced laser eye treatment for vision correction is expected to fuel the growth of the market in the near future.

To learn more about LAMEA Ophthalmic Laser Market report request a free sample copy @ https://www.omrglobal.com/request-sample/lamea-ophthalmic-lasers-market

As per the International Agency for the prevention of Blindness (IAPB), approximately half the blindness in South Africa is caused due to cataracts. The prevalence of blinding bilateral cataracts in Africa is estimated to be around 0.5%. In 2008, the cataract surgical rate in South Africa was 200-400 people. The country has a target to increase this cataract surgical rate to 2,000 in 2020 that will require more ophthalmic lasers for performing cataract surgery. Trachoma is the second leading cause of blindness in South Africa. As per the estimation, more than 2.2 million people are blind from trachoma. This increasing prevalence of chronic eye diseases creates enormous opportunities for ophthalmic laser manufactures and drives the market in the region.

The LAMEA ophthalmic lasers market is segmented on the basis of type, application, and end-user. Based on the type, the market is further classified into SLT laser, Nd: YAG laser, excimer laser, femtosecond laser, cyclodiode laser, and others. There are multiple applications for Nd: YAG lasers and is most commonly used for the treatment of posterior capsular opacification after cataract surgery. Other applications comprise the treatment of recurrent vitreous floaters and corneal erosions. Additionally, based on application, the market is further classified into cataract surgery, refractive surgery, AMD, cornea transplant surgery, glaucoma surgery, diabetic retinopathy, and others. Based on end-user, the market is further classified into hospital, clinic and ambulatory surgical center.

A full report of LAMEA Ophthalmic Laser Market is available at: https://www.omrglobal.com/industry-reports/lamea-ophthalmic-lasers-market

LAMEA Ophthalmic Laser Market-Segmentation

By Type
• Excimer Laser
• Femtosecond Laser
• Cyclodiode Laser
• Nd: YAG Laser
• Selective-Laser-Trabeculoplasty (SLT) Laser
• Others
By Application
• Cataract Surgery
• Glaucoma Surgery
• Diabetic Retinopathy
• Refractive Surgery
• Age-Related Macular Degeneration (AMD)
• Cornea Transplant Surgery
• Others
By End-User
• Hospital
• Clinic
• Ambulatory Surgical Center

REGIONAL ANALYSIS
• Brazil
• Argentina
• UAE
• South Africa
• Nigeria
• Rest of LAMEA

COMPANY PROFILES
• Bausch & Lomb, Inc.
• Boston Scientific Corp.
• Carl Zeiss Meditec AG
• Ellex Medical Lasers, Ltd.
• IRIDEX Corp.
• Johnson & Johnson, Service Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/lamea-ophthalmic-lasers-market

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.